OTCMKTS:KHRNF

Khiron Life Sciences - KHRNF Stock Forecast, Price & News

$0.11

-0.01 (-8.62%)

(As of 02/2/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.10
▼
$0.11
50-Day Range: $0.04
▼
$0.12
52-Week Range: $0.03
▼
$0.22

Volume: 446,630 shs
Average Volume: 327,006 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Khiron Life Sciences (OTCMKTS:KHRNF) Stock

Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of THC (tetrahydrocannabinol) medical cannabis products. The firm operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment involves in growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment operates its medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment focuses on delivering the benefits of CBD and hemp across an array of various branded consumer packaged goods, such as Kuida cosmetics line. The company was founded by Álvaro F. Torres on May 16, 2012 and is headquartered in Vancouver, Canada.

Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

KHRNF Stock News Headlines

January 18, 2023 | proactiveinvestors.com

Khiron Life Sciences shares growth in medical cannabis field throughout South America and Europe

January 9, 2023 | finanznachrichten.de

Khiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance company

February 3, 2023 | Investing Trends (Ad)

Apple, Amazon, and Walmart are Investing in Solar Energy

The global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.

December 1, 2022 | finance.yahoo.com

Khiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)

November 30, 2022 | seekingalpha.com

Khiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call Transcript

November 30, 2022 | finanznachrichten.de

Khiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial Results

November 30, 2022 | finance.yahoo.com

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

November 18, 2022 | finance.yahoo.com

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

February 3, 2023 | Investing Trends (Ad)

Elon Musk Claims Solar Will Soon Power the World

The world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.

November 16, 2022 | finanznachrichten.de

Khiron Life Sciences Corp.: Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom

November 16, 2022 | benzinga.com

Khiron Launches Cannabis Flower Products In Switzerland

October 28, 2022 | msn.com

15 Global Psychedelics Executives To Keep An Eye On In 2022

September 14, 2022 | benzinga.com

Khiron Life Sciences Awarded Best Latin American...

September 13, 2022 | finance.yahoo.com

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference

September 1, 2022 | benzinga.com

Medical Cannabis Company Khiron Launching New Products In Europe

August 29, 2022 | msn.com

Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany

August 29, 2022 | finance.yahoo.com

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

August 22, 2022 | finance.yahoo.com

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

August 9, 2022 | finance.yahoo.com

Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic

August 3, 2022 | proactiveinvestors.com

PharmaDrug closes sale of German cannabis assets to Khiron Life Sciences

July 18, 2022 | finance.yahoo.com

Khiron Appoints Helen Bellwood (ACA) as Interim CFO

July 6, 2022 | finance.yahoo.com

Medical Cannabis Leader Khiron Continues Global Expansion into Spain

June 23, 2022 | finance.yahoo.com

Khiron Announces Results of 2022 Annual General and Special Meeting

June 10, 2022 | finance.yahoo.com

KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION

June 1, 2022 | finance.yahoo.com

KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING

May 31, 2022 | proactiveinvestors.com

PharmaDrug agrees to sell German cannabis distribution subsidiary in exchange for equity in Khiron Life Sciences and $1.1M promissory note

May 25, 2022 | finance.yahoo.com

Khiron to Host First Quarter 2022 Conference Call on May 31, 2022

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:KHRNF
CUSIP: N/A
CIK: N/A
Web: www.khiron.ca
Phone: (702) 527-3564
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Álvaro F. Torres
Chief Executive Officer & Director

Manuel Buendia
Vice President-Operations

Helen Bellwood
Chief Financial Officer

Jairo Espinoza
Vice President-Medical Affairs

Matt Murphy
Vice President-Compliance

Key Competitors

View All Competitors

KHRNF Stock - Frequently Asked Questions

Should I buy or sell Khiron Life Sciences stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares.
View KHRNF analyst ratings or view top-rated stocks.
How have KHRNF shares performed in 2023?: Khiron Life Sciences' stock was trading at $0.0415 at the beginning of the year. Since then, KHRNF stock has increased by 155.4% and is now trading at $0.1060.
View the best growth stocks for 2023 here.

Are investors shorting Khiron Life Sciences?: Khiron Life Sciences saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 120,000 shares, an increase of 46.9% from the December 31st total of 81,700 shares. Based on an average trading volume of 807,600 shares, the days-to-cover ratio is presently 0.1 days.
View Khiron Life Sciences' Short Interest.
What is Khiron Life Sciences' stock symbol?: Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."
How do I buy shares of Khiron Life Sciences?: Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Khiron Life Sciences' stock price today?: One share of KHRNF stock can currently be purchased for approximately $0.11.
How can I contact Khiron Life Sciences?: Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564.

This page (OTCMKTS:KHRNF) was last updated on 2/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial